In this issue:
Proof-of-concept demonstrated for allogeneic CAR T cells
THINK: NKG2D-based CAR T cell therapy
MRD negativity prognostic in transplant eligible patients
Stem cell collection not impacted by daratumumab and lenalidomide induction
Effectiveness of the generic vs original lenalidomide in RRMM
Autologous transplantation in patients with renal impairment
Complement alternative pathway dysregulation linked to carfilzomib-associated TMA
Activity of triplet plitidepsin, bortezomib and dexamethasone in RRMM
PANGEA prediction models outperform IMWG criteria in MGUS and SMM
Lenalidomide desensitisation protocol effective for hypersensitivity-induced rash
Please login below to download this issue (PDF)